Page 16 - Arix Bioscience News Today

Arix Bioscience co-leads $31 million Series A financing for new portfolio companySorriso Pharmaceuticals Arix announces a new portfolio company, Sorriso, with a 26% ownership stakeSeries A proceeds will enable Sorriso Pharmaceuticals to advance its lead programme, a treatment for IBD, into clinical trialsArix M...

Stop watching that documentary on slow-drying paint and check out the London stock market instead

Stop watching that documentary on slow-drying paint and check out the London stock market instead

Investegate announcements from Arix Bioscience Plc, Director/PDMR Shareholding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Depixus®, a biotechnology company developing a unique technology for the fast, accurate, and straightforward extraction of multiomic...

- The financing will support development of a commercial instrument system based on the company's proprietary and disruptive MAGNA technology. - MAGNA is set to unlock the field of dynamic

/PRNewswire/ -- Depixus®, a biotechnology company developing a unique technology for the fast, accurate, and straightforward extraction of multiomic...

Investegate announcements from Arix Bioscience PLC, Depixus raises €30.6M (£26.1 million) in Series A Financing

Disgraced fund manager continues to lay low as he seeks support for his latest venture far from home